| Product Code: ETC058276 | Publication Date: Feb 2021 | Updated Date: Jan 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 200 | No. of Figures: 90 | No. of Tables: 30 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Europe Gastrointestinal Drugs Market Overview |
3.1 Europe Regional Macro Economic Indicators |
3.2 Europe Gastrointestinal Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Europe Gastrointestinal Drugs Market - Industry Life Cycle |
3.4 Europe Gastrointestinal Drugs Market - Porter's Five Forces |
3.5 Europe Gastrointestinal Drugs Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Europe Gastrointestinal Drugs Market Revenues & Volume Share, By Drug Category, 2021 & 2031F |
3.7 Europe Gastrointestinal Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Europe Gastrointestinal Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Europe Gastrointestinal Drugs Market Revenues & Volume Share, By Disease Types, 2021 & 2031F |
4 Europe Gastrointestinal Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Europe Gastrointestinal Drugs Market Trends |
6 Europe Gastrointestinal Drugs Market, 2021 - 2031 |
6.1 Europe Gastrointestinal Drugs Market, Revenues & Volume, By Drug Category, 2021 - 2031 |
6.2 Europe Gastrointestinal Drugs Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.3 Europe Gastrointestinal Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.4 Europe Gastrointestinal Drugs Market, Revenues & Volume, By Disease Types, 2021 - 2031 |
7 Germany Gastrointestinal Drugs Market, 2021 - 2031 |
7.1 Germany Gastrointestinal Drugs Market, Revenues & Volume, By Drug Category, 2021 - 2031 |
7.2 Germany Gastrointestinal Drugs Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.3 Germany Gastrointestinal Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.4 Germany Gastrointestinal Drugs Market, Revenues & Volume, By Disease Types, 2021 - 2031 |
8 United Kingdom Gastrointestinal Drugs Market, 2021 - 2031 |
8.1 United Kingdom Gastrointestinal Drugs Market, Revenues & Volume, By Drug Category, 2021 - 2031 |
8.2 United Kingdom Gastrointestinal Drugs Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8.3 United Kingdom Gastrointestinal Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8.4 United Kingdom Gastrointestinal Drugs Market, Revenues & Volume, By Disease Types, 2021 - 2031 |
9 France Gastrointestinal Drugs Market, 2021 - 2031 |
9.1 France Gastrointestinal Drugs Market, Revenues & Volume, By Drug Category, 2021 - 2031 |
9.2 France Gastrointestinal Drugs Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
9.3 France Gastrointestinal Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9.4 France Gastrointestinal Drugs Market, Revenues & Volume, By Disease Types, 2021 - 2031 |
10 Italy Gastrointestinal Drugs Market, 2021 - 2031 |
10.1 Italy Gastrointestinal Drugs Market, Revenues & Volume, By Drug Category, 2021 - 2031 |
10.2 Italy Gastrointestinal Drugs Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
10.3 Italy Gastrointestinal Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10.4 Italy Gastrointestinal Drugs Market, Revenues & Volume, By Disease Types, 2021 - 2031 |
11 Russia Gastrointestinal Drugs Market, 2021 - 2031 |
11.1 Russia Gastrointestinal Drugs Market, Revenues & Volume, By Drug Category, 2021 - 2031 |
11.2 Russia Gastrointestinal Drugs Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
11.3 Russia Gastrointestinal Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11.4 Russia Gastrointestinal Drugs Market, Revenues & Volume, By Disease Types, 2021 - 2031 |
12 Spain Gastrointestinal Drugs Market, 2021 - 2031 |
12.1 Spain Gastrointestinal Drugs Market, Revenues & Volume, By Drug Category, 2021 - 2031 |
12.2 Spain Gastrointestinal Drugs Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
12.3 Spain Gastrointestinal Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12.4 Spain Gastrointestinal Drugs Market, Revenues & Volume, By Disease Types, 2021 - 2031 |
13 Rest of Europe Gastrointestinal Drugs Market, 2021 - 2031 |
13.1 Rest of Europe Gastrointestinal Drugs Market, Revenues & Volume, By Drug Category, 2021 - 2031 |
13.2 Rest of Europe Gastrointestinal Drugs Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
13.3 Rest of Europe Gastrointestinal Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13.4 Rest of Europe Gastrointestinal Drugs Market, Revenues & Volume, By Disease Types, 2021 - 2031 |
14 Europe Gastrointestinal Drugs Market Key Performance Indicators |
15 Europe Gastrointestinal Drugs Market - Opportunity Assessment |
15.1 Europe Gastrointestinal Drugs Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Europe Gastrointestinal Drugs Market Opportunity Assessment, By Drug Category, 2021 & 2031F |
15.3 Europe Gastrointestinal Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
15.4 Europe Gastrointestinal Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
15.5 Europe Gastrointestinal Drugs Market Opportunity Assessment, By Disease Types, 2021 & 2031F |
16 Europe Gastrointestinal Drugs Market - Competitive Landscape |
16.1 Europe Gastrointestinal Drugs Market Revenue Share, By Companies, 2021 |
16.2 Europe Gastrointestinal Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here